Form 8-K - Current report:
SEC Accession No. 0001628908-25-000141
Filing Date
2025-12-02
Accepted
2025-12-02 07:32:53
Documents
12
Period of Report
2025-12-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 12.01.2025 8-K evh-20251201.htm   iXBRL 8-K 34532
  Complete submission text file 0001628908-25-000141.txt   158472

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evh-20251201.xsd EX-101.SCH 1797
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evh-20251201_lab.xml EX-101.LAB 23451
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evh-20251201_pre.xml EX-101.PRE 13592
15 EXTRACTED XBRL INSTANCE DOCUMENT evh-20251201_htm.xml XML 2944
Mailing Address 1812 NORTH MOORE ST, SUITE 1705 ARLINGTON VA 22209
Business Address 1812 NORTH MOORE ST, SUITE 1705 ARLINGTON VA 22209 571-389-6000
Evolent Health, Inc. (Filer) CIK: 0001628908 (see all company filings)

EIN.: 320454912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37415 | Film No.: 251541603
SIC: 8741 Services-Management Services
(CF Office: 07 Trade & Services)